.jpg)
Cash products:
-- NYSE Euronext's European cash exchanges experienced continued growth, with average daily volume of 1.4 million transactions(1) per day, up 17% compared to April 2007, and a total year-to-date volume increase of 39%. Additionally, Euronext registered strong growth in ETF transactions, with a year-to-date increase of 63% and monthly increase of 31% versus the same period in 2007.
-- NYSE Euronext's U.S. cash exchanges, the New York Stock Exchange and NYSE Arca, reported a total volume(2) increase of 24% in April, year-on-year. Total handled(3) volume also increased 7% during the month of April, compared to the same period last year. NYSE Euronext's U.S. exchanges experienced gains across most product categories in April 2008, including 2.4% for NYSE listed issues, 107% in NYSE Arca and Amex listed issues, and 65% in ETFs compared to April 2007. Effective April 1, 2008, NYSE Arca reduced its fees, delivering the most competitive rates, including the highest rebate and the lowest "take" fee among major U.S. equity markets. This pricing change led to a matched market share gain of 1.2% in Nasdaq-listed issues compared to March 2008.
Derivatives products:
-- NYSE Euronext's derivatives trading operations on Liffe experienced its busiest April ever, with a 34% increase in total contracts traded year-to-date compared to the same period in 2007. In April, Liffe traded more than 97 million futures and options contracts, representing an average daily volume of 4.4 million, up 33% from the same month in 2007. BClear, Liffe's wholesale service for OTC trades, set a new monthly trading record, processing over 20 million contracts in April 2008, up 85% compared to the same month last year. Trading in Liffe's short-term interest rate (STIR) contracts increased by 60% on an average daily volume basis for the month of April 2008 year-on-year. For the year-to-date, STIR volumes were up 52% compared to the same period in 2007.
-- Average daily volume on NYSE Arca Options increased 36% in April 2008, while total volume rose by 33% compared to the same month last year. NYSE Arca Options captured approximately 12% of the trading in all options in April 2008, including 16.4% year-to-date of all trading in the SEC Penny Pilot program.
Listings:
-- In April, NYSE Euronext's U.S. markets added 35 new listings which included four IPOs, representing approximately $2.7 billion raised. On April 28, NYSE-listed Anheuser-Busch opened for trading on NYSE Euronext's Paris market under the ticker symbol "BUD", as a cross-listing on NYSE Euronext's European markets, while continuing to trade on the NYSE, also under the symbol "BUD". Also during April, NYSE Euronext announced the second Chinese company to list on its Alternext Paris market, Huacheng Real Estate (ALHUA), which followed Alternext's first Chinese listing in March.
-- Listing activity of Exchange Traded Products on NYSE Euronext exchanges was strong in April 2008. During the month, NYSE listed one Structured Product while NYSE Arca listed 27 Exchange Traded Products, including nine Exchange Traded Funds and 18 Exchange Traded Notes. Additionally, Euronext listed nine new Exchange Traded Funds, bringing the total number of Exchange Traded Products listed on all NYSE Euronext markets to 617.
Please click here for the Monthly Transaction Activity Data Table.
Note:
Based on fourth-quarter 2007 non-GAAP net revenues (excluding activity assessment fees, and liquidity payments, routing and clearing fees) NYSE Euronext revenues from its primary business activities are represented below as a percentage of total net revenues:
-- Derivatives trading accounts for 23%
-- European cash trading accounts for 19%
-- U.S. cash trading accounts for 12%
-- Market data accounts for 13%
-- Listing accounts for 13%
-- Software and technology services accounts for 14%
On April 30, 2008: EUR 1 = $1.5642
About NYSE Euronext
NYSE Euronext (NYX) operates the world's leading and most liquid exchange group, and seeks to provide the highest levels of quality, customer choice and innovation. Its family of exchanges, located in six countries, includes the New York Stock Exchange, the world's largest cash equities market; Euronext, the Eurozone's largest cash equities market; Liffe, Europe's leading derivatives exchange by value of trading; and NYSE Arca Options, one of the fastest growing U.S. options trading platforms. NYSE Euronext offers a diverse array of financial products and services for issuers, investors and financial institutions in cash equities, options and derivatives, ETFs, bonds, market data, and commercial technology solutions. NYSE Euronext's nearly 4,000 listed companies represent a combined $27.3 / EUR 17.3 trillion in total global market capitalization (as of March 31, 2008), more than four times that of any other exchange group. NYSE Euronext's equity exchanges transact an average daily trading value of approximately $169.6 / EUR 113.2 billion (as of March 31, 2008), which represents more than one-third of the world's cash equities trading. NYSE Euronext is part of the S&P 500 index and the only exchange operator in the S&P 100 index. For more information, please visit www.nyx.com.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2006 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on June 6, 2007 under No. R.07-0089), 2007 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
(1) Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.
(2) Volume figures do not include the NYSE/FINRA Trade Reporting Facility.
(3) Handled shares represent the total number of shares of equity securities internally matched on the NYSE Group's exchanges or routed to and executed at an external market center.
NYSE Euronext
Monthly Volume Summary - Cash Products
----------------------------------------------------------------------
Average Daily Total Volume Total Volume
Volume
------------------ -------------------- --------------
(Unaudited) Apr- Apr- % Chg Apr-08 Apr-07 % Chg YTD % Chg
08 07 2008 vs.
YTD
2007
----- ----- ------ ------ ------ ------ ------- ------
Number of
Trading Days -
European
Markets 22 19 22 19 84
Number of
Trading Days -
U.S. Markets 22 20 22 20 83
European Cash
Products
(trades in
thousands) 1,370 1,168 17.2% 30,139 22,201 35.8% 133,181 38.6%
Equities 1,322 1,119 18.2% 29,086 21,257 36.8% 128,384 39.8%
Exchange-
Traded
Funds 6 5 30.9% 140 93 51.5% 702 63.0%
Structured
Products 36 38 -5.6% 788 722 9.3% 3,613 10.7%
Bonds 6 7 -18.4% 123 131 -5.5% 482 -16.3%
U.S. Cash
Products
(shares in
millions)( 2) 2,822 2,644 6.7% 62,080 52,878 17.4% 276,514 23.6%
NYSE Listed
Issues (1)
NYSE Group
Handled
Volume (2) 2,114 2,064 2.4% 46,508 41,273 12.7% 206,594 20.1%
NYSE Group
Matched
Volume (3) 1,901 1,915 -0.8% 41,813 38,305 9.2% 187,095 15.4%
NYSE Group
TRF Volume
(4) 230 - - 5,054 - - 18,264 -
Total NYSE
Listed
Consolidated
Volume 3,941 3,011 30.9% 86,693 60,211 44.0% 365,033 47.2%
NYSE Group
Share of
Total
Consolidated
Volume
Handled
Volume
(2) 53.6% 68.5% 53.6% 68.5% 56.6%
Matched
Volume
(3) 48.2% 63.6% 48.2% 63.6% 51.3%
TRF Volume
(4) 5.8% - 5.8% - 5.0%
NYSE Arca &
Amex Listed
Issues
NYSE Group
Handled
Volume (2) 293 142 106.6% 6,452 2,839 127.3% 31,570 141.4%
NYSE Group
Matched
Volume (3) 251 120 109.9% 5,517 2,390 130.8% 27,286 141.7%
NYSE Group
TRF Volume
(4) 93 - - 2,037 - - 7,541 -
Total NYSE
Arca & Amex
Listed
Consolidated
Volume 879 394 123.4% 19,346 7,871 145.8% 90,872 169.3%
NYSE Group
Share of
Total
Consolidated
Volume
Handled
Volume
(2) 33.4% 36.1% 33.4% 36.1% 34.7%
Matched
Volume
(3) 28.5% 30.4% 28.5% 30.4% 30.0%
TRF Volume
(4) 10.5% - 10.5% - 8.3%
Nasdaq Listed
Issues
NYSE Group
Handled
Volume (2) 415 438 -5.4% 9,120 8,767 4.0% 38,349 -0.7%
NYSE Group
Matched
Volume (3) 346 360 -3.7% 7,622 7,192 6.0% 31,843 0.3%
NYSE Group
TRF Volume
(4) 194 - - 4,259 - - 17,167 -
Total Nasdaq
Listed
Consolidated
Volume 1,983 2,085 -4.9% 43,619 41,696 4.6% 192,838 9.9%
NYSE Group
Share of
Total
Consolidated
Volume
Handled
Volume
(2) 20.9% 21.0% 20.9% 21.0% 19.9%
Matched
Volume
(3) 17.5% 17.2% 17.5% 17.2% 16.5%
TRF Volume
(4) 9.8% - 9.8% - 8.9%
Exchange-Traded
Funds (1,5)
NYSE Group
Handled
Volume (2) 307 186 64.7% 6,754 3,728 81.2% 33,695 89.2%
NYSE Group
Matched
Volume (3) 265 166 59.9% 5,836 3,319 75.9% 29,328 83.6%
NYSE Group
TRF Volume
(4) 100 - - 2,196 - - 8,551 -
Total ETF
Consolidated
Volume 902 435 107.2% 19,850 8,708 127.9% 95,984 138.9%
NYSE Group
Share of
Total
Consolidated
Volume
Handled
Volume
(2) 34.0% 42.8% 34.0% 42.8% 35.1%
Matched
Volume
(3) 29.4% 38.1% 29.4% 38.1% 30.6%
TRF Volume
(4) 11.1% - 11.1% - 8.9%
NYSE Euronext
----------------------------------------------------------------------
Monthly Volume Summary - Derivatives Products
----------------------------------------------------------------------
Average Daily
Volume
-------------------
(Unaudited; contracts in thousands) Apr-08 Apr- % Chg
07
------ ----- ------
Number of Trading Days - European Markets 22 19
Number of Trading Days - U.S. Markets 22 20
European Derivatives Products 4,441 3,350 32.6%
Total Interest Rate Products 2,483 1,586 56.5%
Short Term Interest Rate Products 2,404 1,502 60.1%
Medium and Long Term Interest Rate Products 80 85 -6.0%
Total Equity Products (6) 1,912 1,708 12.0%
Individual Equity Products 1,371 1,166 17.5%
Equity Index Products 541 542 -0.1%
of which Bclear 941 589 59.8%
Individual Equity Products 847 531 59.6%
Equity Index Products 95 59 61.1%
Commodity Products 44 53 -17.0%
Currency Products 1 2 -46.3%
U.S. Derivatives Products - Equity Options (7)
NYSE Arca Options Contracts 1,423 1,044 36.3%
Total Consolidated Options Contracts 11,835 8,899 33.0%
NYSE Group Share of Total 12.0% 11.7%
NYSE Euronext
----------------------------------------------------------------------
Monthly Volume Summary - Derivatives Products
----------------------------------------------------------------------
Total Volume Total Volume
----------------------- ----------------
(Unaudited; contracts in Apr-08 Apr-07 % Chg YTD 2008 % Chg
thousands) vs.
YTD
2007
-------- ------- ------ --------- ------
Number of Trading Days -
European Markets 22 19 84
Number of Trading Days - U.S.
Markets 22 20 83
European Derivatives Products 97,702 63,645 53.5% 379,947 34.1%
Total Interest Rate Products 54,634 30,140 81.3% 225,923 48.8%
Short Term Interest Rate
Products 52,882 28,530 85.4% 216,988 51.7%
Medium and Long Term
Interest Rate Products 1,752 1,610 8.8% 8,935 1.3%
Total Equity Products (6) 42,071 32,454 29.6% 148,754 16.6%
Individual Equity Products 30,160 22,162 36.1% 92,385 17.0%
Equity Index Products 11,910 10,293 15.7% 56,369 16.0%
of which Bclear 20,712 11,196 85.0% 53,647 63.3%
Individual Equity
Products 18,630 10,080 84.8% 45,352 67.5%
Equity Index
Products 2,082 1,116 86.5% 8,295 43.7%
Commodity Products 977 1,016 -3.9% 5,151 39.7%
Currency Products 21 35 -37.8% 118 -28.1%
U.S. Derivatives Products -
Equity Options (7)
NYSE Arca Options
Contracts 31,303 20,881 49.9% 149,977 65.9%
Total Consolidated Options
Contracts 260,372 177,989 46.3% 1,073,394 47.2%
NYSE Group Share of Total 12.0% 11.7% 14.0% 1.6%
(1)Includes all volume executed in NYSE Group crossing sessions.
Represents the total number of shares of equity securities and ETFs
internally matched on the NYSE Group's exchanges or routed to and
executed at an external market center. NYSE Arca routing includes
(2) odd-lots.
Represents the total number of shares of equity securities and ETFs
(3) executed on the NYSE Group's exchanges.
Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility
(4) (TRF).
(5)Data included in previously identified categories.
Includes all trading activities for Bclear, Euronext.liffe's
(6) clearing service for wholesale equity derivatives.
Includes trading in U.S. equity options contracts, not equity-index
(7) options.
Source: NYSE Euronext, Options Clearing Corporation and
Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash
trading which is double counted to include both buys and sells.
